Dipa Ghedia
About Dipa Ghedia
Dipa Ghedia is a Clinical Trial Manager with extensive experience in managing clinical studies across various therapeutic areas, including Rare Diseases and Infectious Diseases. She has worked at several prominent organizations, including GlaxoSmithKline and Gilead Sciences, and currently holds a position at MeiraGTx.
Work at MeiraGTx
Dipa Ghedia has been serving as a Clinical Trial Manager at MeiraGTx since 2020. In this role, she is responsible for overseeing the planning, execution, and management of clinical trials. Her expertise contributes to the development of innovative therapies in the field of gene therapy. She has focused on ensuring compliance with regulatory requirements and facilitating effective communication among stakeholders involved in clinical research.
Previous Experience in Clinical Trials
Before joining MeiraGTx, Dipa Ghedia held various positions in clinical trial management. She worked at GlaxoSmithKline Pharma GmbH as a Clinical Study Specialist from 2017 to 2019, where she gained valuable experience in clinical study operations. Following this, she was employed at Gilead Sciences as a Clinical Trials Management Associate in London from 2019 to 2020. Additionally, she worked at Royal Free London NHS Foundation Trust as a Clinical Trial Practitioner from 2016 to 2017 and held roles as a Clinical Trial Administrator and Clinical Trial Technician between 2011 and 2016.
Education and Expertise
Dipa Ghedia earned her Bachelor of Science degree in Biomedical Science from Kingston University, completing her studies from 2005 to 2008. Her educational background provides her with a solid foundation in the biological sciences, which is essential for her work in clinical trials. She possesses expertise in managing both observational and interventional clinical studies, with a focus on patient recruitment and engagement.
Therapeutic Areas of Experience
Dipa Ghedia has extensive experience in various therapeutic areas, including Rare Diseases, Infectious Diseases, Inflammation, and Respiratory conditions. Her work spans both sponsor and NHS site levels, allowing her to understand the complexities of clinical trials from multiple perspectives. This breadth of experience enhances her ability to manage diverse clinical studies effectively.